ClinicalTrials.gg
CompletedNCT02194920Updated Nov 5, 2014

Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function

An observational study in Thyroid Goiter, Thyroid Carcinoma and Multinodular Goiter, sponsored by University of Roma La Sapienza. Completed at 1 site in Italy. Per ClinicalTrials.gov, last updated 2014-11-05.

Sponsored by University of Roma La Sapienza · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Sex
All
01

Study summary

The purpose of this study is to evaluate safety and effectiveness of normal parathyroid tissue reimplantation in forearm subcutaneous tissue in case of accidental removal of parathyroid gland during thyroid surgery.

02

Conditions studied

  • Thyroid Goiter
  • Thyroid Carcinoma
  • Multinodular Goiter
  • Graves Diseases
03

In context

Goiter

66 studies on the registry are indexed under Goiter; 11 are open to participants now.

This study's enrollment of 20 is below the median of 104 across 23 observational studies indexed under Goiter.

Browse Goiter studies →

Lead sponsor

University of Roma La Sapienza is the lead sponsor of 398 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients receiving thyroid surgery with accidental removal or devascularization of normal parathyroid gland

Eligibility criteria

Inclusion Criteria:

  • Patients affected by benign thyroid disease undergoing thyroidectomy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Groups and cohorts

  • Parathyroid reimplantation

    Procedure: Thyroidectomy and parathyroid reimplantation in forearm subcutaneous tissue

Interventions

  • ProcedureThyroidectomy and parathyroid reimplantation in forearm subcutaneous tissue
06

What researchers measure

Primary outcomes

  1. Assessment of parathyroid tissue graft function by selective (left or right) parathormone measurement by vein blood sample

    The primary outcome will be the assessment of reimplanted parathyroid function, evaluated by intact Parathormone (iPTH) measurement by separate blood samples (left and right arm) at 7 days, 1 month and 3 months after surgery. Ratio of 1.5 between the iPTH levels in the arm receiving graft and the opposite arm will be predictive of graft functionality

    Time frame: up to 3 months

07

Study locations

1 site
  • General Surgery Unit, ICOT Hospital
    Latina, 04100, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 5, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02194920
Responsible party
Giuseppe Cavallaro (Giuseppe Cavallaro, MD PhD, University of Roma La Sapienza) — Principal investigator
First posted
Jul 18, 2014
Start date
Oct 2014
Primary completion
Oct 2014
Completion
Nov 2014
Last update
Nov 5, 2014
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion